Lupin

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE326A01037
  • NSEID: LUPIN
  • BSEID: 500257
INR
2,010.00
11 (0.55%)
BSENSE

Nov 20

BSE+NSE Vol: 6.6 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 641789,
    "name": "Lupin",
    "stock_name": "Lupin",
    "full_name": "Lupin Ltd.",
    "name_url": "stocks-analysis/lupin",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,010.00",
    "chg": 11,
    "chgp": "0.55%",
    "dir": 1,
    "prev_price": "1,999.00",
    "mcapval": "91,642.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500257,
    "symbol": "LUPIN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE326A01037",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "6.6 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/lupin-641789-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Lupin Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/lupin-ltd-is-rated-sell-by-marketsmojo-4260546",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/LupinLtd_mojoScore_4260546.png",
        "date": "2026-11-13 10:12:22",
        "description": "Lupin Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 November 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 13 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Lupin Declines 0.95% Amid Margin Pressures and Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lupin-declines-095-amid-margin-pressures-and-mixed-market-signals-4255655",
        "imagepath": "",
        "date": "2026-11-07 16:06:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Stock opens at Rs.1,996.55, declines 0.62% amid Sensex rally</p>\n                    <p><strong>3 Nov:</strong> Significant open interest surge in derivatives despite modest price gain</p>\n                    <p><strong>4 Nov:</strong> Q2 results reveal strong revenue growth but margin contraction</p>\n                    <p><strong>5 Nov:</strong> Stock dips 1.36% on heavy volume amid margin concerns</p>\n                    <p><strong>6 Nov:</strong> Week closes at Rs.1,990.00, down 0.31% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-v..."
      },
      {
        "title": "Lupin Ltd Q2 2026 Results Show Margin Pressure Amid Revenue Growth",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lupin-ltd-q2-2026-results-show-margin-pressure-amid-revenue-growth-4250855",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/LupinLtd_fintrenddot_4250855.png",
        "date": "2026-11-04 13:00:36",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a marked shift in its financial trajectory during the September 2026 quarter. Despite robust net sales growth, the company’s profitability metrics have deteriorated, prompting a downgrade in its Mojo Grade from Hold to Sell. This article analyses Lupin’s recent quarterly performance in the context of its historical trends and broader market movements."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-amid-mixed-market-signals-4249519",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/LupinLtd_oi_spurts_by_underlying_4249519.png",
        "date": "2026-11-03 15:00:10",
        "description": "Lupin Ltd., a mid-cap pharmaceutical player, has witnessed a notable 11.05% increase in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest price decline of 0.19% on 3 Nov 2026, the surge in open interest and volume patterns suggest a complex interplay of directional bets and market sentiment within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Lupin Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/lupin-ltd-is-rated-hold-by-marketsmojo-4247359",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/LupinLtd_mojoScore_4247359.png",
        "date": "2026-11-02 10:10:02",
        "description": "Lupin Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 02 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Lupin Ltd. Declines 1.57% Amid 52-Week Lows and Rising Derivatives Activity",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lupin-ltd-declines-157-amid-52-week-lows-and-rising-derivatives-activity-4237445",
        "imagepath": "",
        "date": "2026-10-24 16:05:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Oct 19:</strong> Stock opens at Rs.1,953.75, marginally down amid broader market weakness</p>\n                    <p><strong>Oct 21:</strong> Slight recovery to Rs.1,957.00 despite Sensex decline</p>\n                    <p><strong>Oct 22:</strong> Lupin hits 52-week low of Rs.1,897.25; open interest surges 13.4%</p>\n                    <p><strong>Oct 23:</strong> New 52-week low of Rs.1,893.25; open interest rises 10.96%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,955.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\"..."
      },
      {
        "title": "Lupin Ltd. Sees Sharp Open Interest Surge Amidst Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lupin-ltd-sees-sharp-open-interest-surge-amidst-mixed-market-signals-4236501",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/LupinLtd_oi_spurts_by_underlying_4236501.png",
        "date": "2026-10-23 15:00:35",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential shifts in investor positioning. Despite trading close to its 52-week low, the stock’s derivatives activity suggests evolving directional bets that merit close attention from market participants."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Amidst Market Pressure",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-amidst-market-pressure-4236274",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/LupinLtd_oi_spurts_by_underlying_4236274.png",
        "date": "2026-10-23 13:00:20",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.9% surge in open interest in its derivatives segment, signalling heightened market activity despite the stock trading near its 52-week low. This development comes amid a backdrop of subdued price performance and declining investor participation, raising questions about evolving market positioning and potential directional bets."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Amid Bearish Price Action",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-amid-bearish-price-action-4234297",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/LupinLtd_oi_spurts_by_underlying_4234297.png",
        "date": "2026-10-22 15:00:31",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a notable 13.4% surge in open interest in its derivatives segment on 22 Oct 2026, despite the stock underperforming the sector and closing near its 52-week low. This divergence between rising open interest and declining price signals evolving market positioning and potential directional bets among traders."
      }
    ],
    "total": 166,
    "sid": "641789",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/lupin-641789"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Nov-2026",
      "details": "Newspaper Publication regarding the Notice of Postal Ballot and Remote E-Voting.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "16-Nov-2026",
      "details": "Notice of Postal Ballot dated November 03 2026 along with Explanatory Statement.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "12-Nov-2026",
      "details": "Lupin Announces European Launch of Biosimilar Ranibizumab.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has declared <strong>900%</strong> dividend, ex-date: 17 Jul 26",
          "dt": "2026-07-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>2:10</strong> stock split, ex-date: 27 Aug 10",
          "dt": "2010-08-27",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 11 Aug 06",
          "dt": "2006-08-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

17-Nov-2026 | Source : BSE

Newspaper Publication regarding the Notice of Postal Ballot and Remote E-Voting.

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

16-Nov-2026 | Source : BSE

Notice of Postal Ballot dated November 03 2026 along with Explanatory Statement.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

12-Nov-2026 | Source : BSE

Lupin Announces European Launch of Biosimilar Ranibizumab.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Lupin Ltd. has declared 900% dividend, ex-date: 17 Jul 26

stock-summary
SPLITS

Lupin Ltd. has announced 2:10 stock split, ex-date: 27 Aug 10

stock-summary
BONUS

Lupin Ltd. has announced 1:1 bonus issue, ex-date: 11 Aug 06

stock-summary
RIGHTS

No Rights history available